Olivares Concepcion, Solano Francisco, García-Borrón Jose C
Department of Biochemistry and Molecular Biology, School of Medicine, University of Murcia, Apto 4021, Campus Espinardo, Murcia 30100, Spain.
J Biol Chem. 2003 May 2;278(18):15735-43. doi: 10.1074/jbc.M300658200. Epub 2003 Feb 20.
Tyrosinase, the rate-limiting enzyme in mammalian melanogenesis, is a copper-containing transmembrane glycoprotein. Tyrosinase undergoes a complex post-translational processing before reaching the melanosomal membrane. This processing involves N-glycosylation in several sites, including one located in the CuB copper binding site, movement from the endoplasmic reticulum (ER) to the Golgi, copper binding, and sorting to the melanosome. Aberrant processing is causally related to the depigmented phenotype of human melanomas. Moreover, some forms of albinism and several other pigmentary syndromes are considered ER retention diseases or trafficking defects. A critical step in tyrosinase maturation is the acquisition of an ER export-competent conformation recognized positively by the ER quality control system. However, the minimal structural requirements allowing exit from the ER to the Golgi have not yet been identified for tyrosinase or other melanosomal proteins. We addressed this question by analyzing the enzymatic activity and glycosylation pattern of mouse tyrosinase point mutants and chimeric constructs, where selected portions of tyrosinase were replaced by the homologous fragments of the highly similar tyrosinase-related protein 1. We show that a completely inactive tyrosinase point mutant lacking a critical histidine residue involved in copper binding is nevertheless able to exit from the ER and undergo further processing. Moreover, we demonstrate that tyrosinase displays at least two sites whose glycosylation is post-translational and most likely conformation-dependent and that a highly specific interaction involving the CuB site is essential not only for correct glycosylation but also for exit from the ER and enzymatic activity.
酪氨酸酶是哺乳动物黑色素生成中的限速酶,是一种含铜的跨膜糖蛋白。酪氨酸酶在到达黑素体膜之前会经历复杂的翻译后加工过程。这种加工涉及多个位点的N-糖基化,包括位于铜离子结合位点CuB处的一个位点,从内质网(ER)转运至高尔基体,铜离子结合,以及分选至黑素体。异常加工与人类黑色素瘤的色素脱失表型存在因果关系。此外,某些形式的白化病和其他几种色素沉着综合征被认为是内质网滞留疾病或转运缺陷。酪氨酸酶成熟过程中的一个关键步骤是获得一种能被内质网质量控制系统正向识别的具备内质网输出能力的构象。然而,对于酪氨酸酶或其他黑素体蛋白而言,尚未确定允许其从内质网转运至高尔基体的最小结构要求。我们通过分析小鼠酪氨酸酶点突变体和嵌合构建体的酶活性和糖基化模式来解决这个问题,在这些构建体中,酪氨酸酶的选定部分被高度相似的酪氨酸酶相关蛋白1的同源片段所取代。我们发现,一个完全无活性的酪氨酸酶点突变体,缺失了参与铜离子结合的关键组氨酸残基,但仍能够从内质网中输出并进行进一步加工。此外,我们证明酪氨酸酶至少有两个位点的糖基化是翻译后修饰的,并且很可能依赖于构象,而且涉及CuB位点的高度特异性相互作用不仅对于正确的糖基化至关重要,对于从内质网输出和酶活性也必不可少。